arrow
Back
M

Muhamed Baljević

vanderbilt university medical center

19H-index
144Paper Count
3.1KCitation Count
Published Papers 28
Publication Date
Long-term extended-interval teclistamab and talquetamab dosing without step-up dosing in previously treated multiple myeloma
err2026-08-12
err0
errOAAI
errCallee Brooks; Leslie Mader; Kathryn Kennedy; Phyu Thin Naing; Salyka Sengsayadeth; Bhagirathbhai Dholaria; Adetola Kassim; Sarah Profitt; Muhamed Baljevic
errShare
errSave
Retreatment with talquetamab and pomalidomide in triple-class–BCMA–GPRC5D refractory myeloma
err2026-05-10
err0
errOAAI
errKian J. Rahbari; Gliceida M. Galarza Fortuna; Bhagirathbhai Dholaria; Douglas W. Sborov; Muhamed Baljevic
errShare
errSave
Experiences with real-world teclistamab administration in community and outpatient settings: a mixed-methods study of hematology providers
err2026-02-01
err0
PREAI
errDerman, Benjamin; Jijun Liu, Jane; Bouchard, Nicholas; Figg, Lindsay; Laporte, Justin; Goorha, Salil; Pagan, Kaley; Tandra, Anand; Varshavsky, Asya; Ko, Gilbert; Lin, Dee; Paner-Straseviciute, Agne; Roach, Meaghan; Murphy, Richard; Jamaleddine, Amal; Bariahtaris, Nicole; Fowler, Jessica; Gupta-Werner, Niodita; Baljevic, Muhamed
errShare
errSave
Ex Vivo Treatment Response Prediction in Multiple Myeloma: Assay Formats, Clinical Correlation, and Future Directions
errCancers
IF4.4
err2026-01-28
err0
errOAAI
errGavin R. Oliver; Carlton C. Barnett; Kendra E. Hightower; Yubin Kang; Muhamed Baljevic
errShare
errSave
Diagnostic Journeys and Delays in AL Amyloidosis: Insights from a Cross-Sectional Patient Survey
err2026-01-13
err0
PREAI
errNadine H. Abdallah; Jay R. Hydren; Mason S. Barnes; Andrew Wood; Jorge Arturo Hurtado Martínez; Sascha A. Tuchman; Jeffrey A. Zonder; Giada Bianchi; Heather J. Landau; Muhamed Baljevic; James Hoffman; Aman Godara; Jennifer M. Ahlstrom; Morie Gertz
errShare
errSave
Multiple Myeloma, Version 5.2026
err2026-01-01
err2
PREAI
errKumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson, Larry D.; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Costello, Caitlin; D'angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Godara, Amandeep; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C.; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy J.; Rosenberg, Aaron; Sarosiek, Shayna R.; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Vogl, Dan; Ye, Jing Christine; Kovach, Emily; Kumar, Rashmi
errShare
errSave
Feasibility of outpatient administration of ciltacabtagene autoleucel and reduction in healthcare utilization cost: the Vanderbilt experience
err2025-12-27
err0
PREAI
errIhunayachi Ohuabunwa; Bhagirathbhai Dholaria; Megan Wanca; Grace Johnson Mercadante; Phavina Akhom; Brittney Baer; Ali Nur; Leslie Mader; Sarah Moseley; Eden Biltibo; Andrew Jallouk; Reena Jayani-Kosarzycki; James Jerkins; Adetola Kassim; Nancy Long; David Morgan; Vivek Patel; Shakthi Bhaskar; Bipin Savani; Salyka Sengsayadeth; Muhamed Baljevic; Olalekan O. Oluwole
errShare
errSave
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacy
err2025-09-22
err0
errOAAI
errMuhamed Baljevic; Gary Schiller; Tomer M. Mark; Dane R. Van Domelen; Cristina Gasparetto
errShare
errSave
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025
err2025-05-01
err0
PREAI
errKumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson Jr, Larry D.; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Costello, Caitlin; D'Angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Godara, Amandeep; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C.; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Vogl, Dan; Kovach, Emily; Kumar, Rashmi
errShare
errSave
errShare
errSave
errShare
errSave
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
err2024-05-17
err2
errOAAI
errWhite, Darrell; Schiller, Gary J.; Madan, Sumit; Lentzsch, Suzanne; Chubar, Evgeni; Lavi, Noa; Van Domelen, Dane R.; Bentur, Ohad S.; Baljevic, Muhamed
errShare
errSave
Waldenstro m Macroglobulinemia/ Lymphoplasmacytic Lymphoma, Version 2.2024
err2024-01-01
err1
errOAAI
errKumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson, Larry D.; Baljevic, Muhamed; Campagnaro, Erica; Baz, Rachid; Castillo, Jorge J.; Costello, Caitlin; 'Angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Sborov, Douglas; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Snedeker, Jenna; Kumar, Rashmi
errShare
errSave
Multiple Myeloma, Version 2.2024
err2023-12-01
err23
errOAAI
errKumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson Jr, Larry D.; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Castillo, Jorge J.; Costello, Caitlin; D'Angelo, Christopher; Devarakonda, Srinivas; Elsedawy, Noura; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C.; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Sborov, Douglas; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Kumar, Rashmi; Snedeker, Jenna
errShare
errSave
Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors
err2023-10-26
err8
errOAAI
errBinder, Adam F.; Walker, Christopher J.; Mark, Tomer M.; Baljevic, Muhamed
errShare
errSave
Multiple Myeloma, Version 3.2022 Featured Updates to the NCCN Guidelines
err2022-01-01
err115
PREAI
errCallander, Natalie S.; Baljevic, Muhamed; Adekola, Kehinde; Anderson, Larry D.; Campagnaro, Erica; Castillo, Jorge J.; Costello, Caitlin; Devarakonda, Srinivas; Elsedawy, Noura; Faiman, Matthew; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Liedtke, Michaela; Martin, Thomas; Omel, James; Sborov, Douglas; Shain, Kenneth; Stockerl-Goldstein, Keith; Weber, Donna; Berardi, Ryan A.; Kumar, Rashmi; Kumar, Shaji K.
errShare
errSave
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients
err2021-11-20
err25
errOAAI
errGasparetto, Cristina; Schiller, Gary J.; Tuchman, Sascha A.; Callander, Natalie S.; Baljevic, Muhamed; Lentzsch, Suzanne; Rossi, Adriana C.; Kotb, Rami; White, Darrell; Bahlis, Nizar J.; Chen, Christine, I; Sutherland, Heather J.; Madan, Sumit; LeBlanc, Richard; Sebag, Michael; Venner, Christopher P.; Bensinger, William, I; Biran, Noa; Ammu, Sonia; Ben-Shahar, Osnat; DeCastro, Andrew; Van Domelen, Dane; Zhou, Tianjun; Zhang, Chris; Bentur, Ohad S.; Shah, Jatin; Shacham, Sharon; Kauffman, Michael; Lipe, Brea
errShare
errSave